An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...] …
Category: Providers
The federal government’s recent threat to penalize Johnson & Johnson (J&J) for its unapproved 340B rebate model could spark a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The sponsor of new Senate legislation that would codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Louisiana providers can enroll in the 340B program outside of the formal enrollment period amid disaster relief efforts following Hurricane [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Beginning Oct. 1, AstraZeneca will tighten its 340B contract pharmacy restrictions to require claims data on 340B utilization at contract [...] …